HOME >> BIOLOGY >> NEWS
Early predictor of breast cancer aggressiveness

Physicians may be able to make early decisions on the best treatment for breast cancer, thanks to research published in Breast Cancer Research today. A gene involved in the adhesion of cells is less active in breast tumors with a poor prognosis than those that are less aggressive, researchers found.

Measuring the activity of the ALCAM gene in primary breast tumors could give physicians advanced warning about the likely clinical outcome of the disease. This should help them decide whether to prescribe a more aggressive treatment regimen, such as chemotherapy, much earlier in the diagnostic process.

Dr Judy King and colleagues, from University of South Alabama and University of Wales College of Medicine, compared the expression of the gene for the Activated Leukocyte Cell Adhesion Molecule (ALCAM) in normal breast tissue and tissue samples from primary breast tumors. To do this they counted the number of mRNA transcripts of the ALCAM gene in the different samples.

The researchers found that the ALCAM gene was significantly less active in higher-grade tumors compared to lower-grade tumors, and in tumors with a worse prognosis compared to those with a better prognosis.

"Tumors from patients who died of breast cancer had significantly lower levels of ALCAM transcripts than those with primary tumors but no metastatic disease or local recurrence," write the researchers.

They continue: "The data clearly suggest that decreased ALCAM expression in the primary tumor is of clinical significance in breast cancer, and that reduced expression indicates a more aggressive phenotype and poor prognosis."

They suggest that quantitative PCR, to measure the number of ALCAM transcripts in a tissue sample from a primary breast tumor, could be used to identify these more aggressive tumors at an early stage.

As ALCAM is involved in keeping cells together in a clump, the researchers hypothesize that reduced expression of the gene might
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-631-9931
BioMed Central
27-Jun-2004


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early treatment confirmed as key to stroke recovery
6. Early identification of kidney disease cost-effective only when directed at high-risk patients
7. Early promise for treatment of Ebola
8. Early treatment can prevent severe vision loss in premature infants
9. Early hominids may have behaved more human than we had thought
10. Early infection and rejection detection
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/25/2018)... ... 2018 , ... Researchers at the Icahn School of Medicine ... a long-standing computational concept known as “blacklisting,” which is commonly employed as a ... as a filter to single out genetic variations in patient genomes and exomes ...
(Date:12/19/2018)... ... December 19, 2018 , ... OrthoSpace Ltd. ... Arthroscopy evaluating the use of novel surgical techniques, including the OrthoSpace ... represent a painful, disabling condition for which there are historically few treatment options. ...
(Date:12/13/2018)... ... ... Study Protocol Summary of QC Procedure , 1 – Patient Enrolment (with ... the site., 3 - Three photos captured with Apple iPad and transferred to each ... Photos moved to eAdjudication® and submitted to Reviewers., 6 - Reviewers (blinded) repeats ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... ... adopted from a local shelter when he was around two years old. According to ... after he was adopted, he tore his right cruciate ligament. Though he had his ... a traumatic injury. , Sure enough, when Rascal was about nine years old, he began ...
(Date:1/8/2019)... ... 08, 2019 , ... The American Society of Gene and Cell Therapy’s ... selection committee made up of industry leaders identified by the ASGCT board of directors. ... awards created to support ASGCT members designing transformative pilot studies in gene and cell ...
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life ... cells in blood, has been named as a partner in Medigen Biotech’s upcoming ... cell therapies for cancer treatment, will use CellMax Life’s circulating tumor cell platform ...
(Date:12/19/2018)... FREDERICK, Md. (PRWEB) , ... December 19, 2018 ... ... solutions for Life Science, announces the validated release of Limfinity® version 7.1. The ... another important technical offering from RURO as 2018 comes to an end. , ...
Breaking Biology Technology:
Cached News: